We can’t show the full text here under this license.
Abstract
mRNA therapeutics offer a versatile platform to address previously untreatable diseases.
- Recent advancements in biotechnology have enabled the efficient production of proteins, antibodies, and peptides via mRNA.
- The success of mRNA vaccines during the COVID-19 pandemic demonstrates their potential for rapid and scalable responses to infectious diseases.
- Innovations in mRNA technology include optimizing constructs for therapeutic efficacy and developing new delivery vehicles.
- Modulation of the immune response is a significant aspect of mRNA vaccines, impacting their effectiveness.
- Applications of mRNA therapeutics may extend to genetic disorders, infectious diseases, and cancer, although challenges in delivery efficiency and production scalability remain.
Simplified